Auditory Screening in Newborns after Maternal SARS-CoV-2 Infection: An Overview

Virginia Fancello1, Giuseppe Fancello2, Elisabetta Genovese3

  • 1ENT & Audiology Unit, Department of Neurosciences, University Hospital of Ferrara, 44124 Ferrara, Italy.

PubMed

Insights

Maternal COVID-19 infection during pregnancy does not definitively link to congenital hearing loss in newborns. Further research is needed to establish a clear correlation between SARS-CoV-2 and hearing impairment.

Area of Science:

  • Virology
  • Pediatrics
  • Genetics

Background:

  • Congenital hearing loss is linked to various viruses.
  • The SARS-CoV-2 pandemic prompted investigations into its potential effects on newborns.
  • Maternal COVID-19 infection is a suspected factor in congenital hearing loss.

Purpose of the Study:

  • To systematically review and assess the potential association between maternal SARS-CoV-2 infection during pregnancy and congenital hearing loss in infants.

Main Methods:

  • Systematic review adhering to PRISMA criteria.
  • Searched Medline and Embase databases from March 2020 to February 2023.
  • Analyzed nine selected studies out of 924 initial candidates.

Main Results:

  • Included 1687 children born to mothers with COVID-19 during pregnancy.
  • Identified a 0.7% incidence of hearing loss (12/1688).
  • Noted missing details on hearing loss type and variable follow-up periods; significant false positives occurred during initial screening.

Conclusions:

  • A definitive correlation between maternal COVID-19 and congenital hearing loss is not established.
  • Further research is required to confirm any link.
  • The current evidence is insufficient to conclude a causal relationship.
Abstract

Related Concept Videos